References
- MosolovSNPotapovAVUshakovUVShafarenkoAAKostyukovaABDesign and validation of standardized clinical and functional remission criteria in schizophreniaNeuropsychiatr Dis Treat20141016718124511232
- AndreasenNCCarpenterWTJrKaneJMLasserRAMarderSRWeinbergerDRRemission in schizophrenia: proposed criteria and rationale for consensusAm J Psychiatry2005162344144915741458
- OplerMGYangLHCaleoSAlbertiPStatistical validation of the criteria for symptom remission in schizophrenia: preliminary findingsBMC Psychiatry200773517650312
- WunderinkLNienhuisFJSytemaSWiersmaDPredictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychoticsSchizophr Bull200733379279616894026
- DunayevichESethuramanGEnersonMTaylorCCLinDCharacteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomesSchizophr Res200686130030816860974
- AlAqeelBMargoleseHCRemission in schizophrenia: critical and systematic reviewHarv Rev Psychiatry201220628129723216066
- BoterHPeuskensJLibigerJEUFEST study groupEffectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)Schizophr Res20091152–39710319819114
- HelmchenHEthical issues in naturalistic versus controlled trialsDialogues Clin Neurosci201113217318221842614
References
- MosolovSNPotapovAVUshakovUVShafarenkoAAKostyukovaABDesign and validation of standardized clinical and functional remission criteria in schizophreniaNeuropsychiatr Dis Treat20141016718124511232
- AndreasenNCCarpenterWTJrKaneJMLasserRAMarderSRWeinbergerDRRemission in schizophrenia: proposed criteria and rationale for consensusAm J Psychiatry2005162344144915741458
- AlAqeelBMargoleseHCRemission in schizophrenia: critical and systematic reviewHarv Rev Psychiatry201220628129723216066
- LasserRABossieCAGharabawiGMKaneJMRemision in schizophrenia: Results from a 1-year study of long-acting risperidone injectionSchizophr Res2005772–321522715908183
- HelldinLKaneJMKarilampiUNorlanderTArcherTRemission and cognitive ability in a cohort of patients with schizophreniaJ Psychiatr Res200640873874516963087
- De HertMvan WinkelRWampersMKaneJvan OsJPeuskensJRemission criteria for schizophrenia: evaluation in a large naturalistic cohortSchizophr. Res200792687317336500
- SanLCiudadAAlvarezEBobesJGilaberteISymptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional studyEur Psychiatry200722849049817904337
- WunderinkLSytemaSNienhuisFJWiersmaDClinical recovery in first-episode psychosisSchizophr Bull200935236236918990715
- MosolovSNPotapovAVDediurinaIuMUshakovIuVTsukarziEEThe validation of international criteria for remission in schizophrenia in the outpatient populationZh Nevrol Psikhiatr Im S S Korsakova20101105 Pt 17175 Russian21322130
- LiCTSuTPChouYHSymptomatic resolution among Chinese patients with schizophrenia and associated factorsJ Formos Med Assoc2010109537838820497871
- WolterAPreussUWKrischkeNRWongWMZimmermannJRemission, prediction and stability of symptoms in schizophrenia: A naturalistic 12-month follow-up studyInt J Psychiatry Clin Pract2010143160167
- KuriharaTKatoMRevergerRTirtaIGRemission in schizophrenia: a community- based 6-year follow-up study in BaliPsychiatry Clin Neurosci20116547648221851456
- ZimmermannJWolterAKrischkeNRPreussUWWobrockTFalkaiPResponse and remission in schizophrenic subjectsNervenarzt2011821114401448 German [with English abstract]21221520
- LevineSZRabinowitzJAscher-SvanumHFariesDELawsonAHExtent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE studySchizophr Res20111331–3424622000938
- MosolovSNPotapovAVUshakovUVRemission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient populationAnn Gen Psychiatry2012111122221826
- PotapovAVTsukarziEEMosolovSNResponse, Remission and Relapse during the long-term treatment of schizophrenia patients with long-acting injectable risperidone versus olanzapine. In: Abstracts from the XXVI CINP Congress, Munich, July 13–17, 2008Intern Jour Neuropsychopharmacology200811Suppl S1158
- MosolovSNTsukarziEEPotapovAVComparative efficacy, tolerability and influence on social functioning of risperidone prolong (Consta) and olanzapine during the long-term treatment of schizophrenia and schizoaffective disorder (randomized controlled study)Sovremennaya Terapia Psikhicheskyh Rasstroistv200821018 Russian [with English abstract]